318 results on '"Chan, Anthony Wing‐Hung"'
Search Results
2. Differential Diagnoses of Hepatocellular Carcinoma
3. Steatohepatitic Hepatocellular Carcinoma
4. General Histopathological Features of Hepatocellular Carcinoma
5. Macrotrabecular-Massive Hepatocellular Carcinoma
6. Gross Morphology of Hepatocellular Carcinoma
7. Precursor Lesions of Hepatocellular Carcinoma
8. Tumour Staging for Hepatocellular Carcinoma
9. Lymphocyte-Rich Hepatocellular Carcinoma
10. Ancillary Tests for Hepatocellular Carcinoma
11. Hepatocellular Carcinoma with Cytokeratin 19 Expression
12. Combined Hepatocellular-Cholangiocarcinoma
13. Post-treatment Changes of Hepatocellular Carcinoma
14. Fibrolamellar Hepatocellular Carcinoma
15. Clear Cell Hepatocellular Carcinoma
16. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
17. Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion
18. Introduction
19. Atlas of Hepatocellular Carcinoma Pathology
20. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
21. Consensus statements on endoscopic ultrasound‐guided tissue acquisition. Guidelines from the Asian Endoscopic Ultrasound Group.
22. Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease
23. A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma
24. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma
25. Multiple modulatory activities of Andrographis paniculata on immune responses and xenograft growth in esophageal cancer preclinical models
26. Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma
27. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
28. Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes
29. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
30. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates
31. Irreversible Electroporation of the Femoral Neurovascular Bundle: Imaging and Histologic Evaluation in a Swine Model
32. Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients
33. Non-alcoholic fatty liver disease: the pathologist’s perspective
34. A Sequential Machine Learning Model for Identifying At-risk NASH by Combining Liver Stiffness Measurement and Protein Biomarkers
35. Liver Injury Is Common Among Chronic Abusers of Ketamine
36. Chapter 7 - Artificial intelligence in prediction of steatosis and fibrosis of nonalcoholic fatty liver disease
37. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
38. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway
39. Association Between Anthropometric Parameters and Measurements of Liver Stiffness by Transient Elastography
40. Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study
41. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
42. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
43. Turning immunologically cold tumors into hot ones by activating hepatoma-intrinsic FADD/NF-κB/CCL5 pathway
44. Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems
45. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings
46. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease
47. Non-alcoholic fatty liver disease: the pathologist’s perspective.
48. Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade
49. Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
50. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.